Department of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.
Department of Pharmacology, Faculty of Pharmacy, Cukurova University, Adana, Turkey.
Drug Discov Today. 2022 Oct;27(10):103327. doi: 10.1016/j.drudis.2022.07.012. Epub 2022 Jul 26.
Throughout 2021, the scientific and medical communities were concentrated on dealing with the acute morbidity and mortality induced by the COVID-19 pandemic due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We reviewed the present data for adverse effects of COVID-19 on the different parts of the male urogenital system during the dynamic situation of the COVID-19 pandemic. With the approval of COVID-19 vaccinations, there is a ray of hope at the end of this dark tunnel and a chance to look ahead for the management of long-term consequences in males with urogenital illness. A multidisciplinary investigation of these cases could provide information for establishing and optimizing treatment protocols.
2021 年全年，科学界和医学界都集中精力应对由严重急性呼吸系统综合征冠状病毒 2（SARS-CoV-2）引起的 COVID-19 大流行所导致的急性发病率和死亡率。我们回顾了 COVID-19 大流行期间 COVID-19 对男性泌尿生殖系统不同部位的不良影响的现有数据。随着 COVID-19 疫苗的批准，在这条黑暗隧道的尽头出现了一线希望，有机会为患有泌尿生殖系统疾病的男性的长期后果的管理展望未来。对这些病例进行多学科调查可以为制定和优化治疗方案提供信息。
